A detailed history of Texas Permanent School Fund transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Texas Permanent School Fund holds 80,235 shares of NBIX stock, worth $10.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
80,235
Previous 87,087 7.87%
Holding current value
$10.1 Million
Previous $12 Million 8.04%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$130.86 - $143.19 $896,652 - $981,137
-6,852 Reduced 7.87%
80,235 $11 Million
Q1 2024

May 03, 2024

BUY
$130.4 - $143.74 $288,314 - $317,809
2,211 Added 2.6%
87,087 $12 Million
Q4 2023

Feb 08, 2024

BUY
$106.07 - $132.76 $205,881 - $257,687
1,941 Added 2.34%
84,876 $11.2 Million
Q3 2023

Nov 09, 2023

SELL
$94.02 - $117.1 $279,991 - $348,723
-2,978 Reduced 3.47%
82,935 $9.33 Million
Q2 2023

Aug 07, 2023

SELL
$89.53 - $104.87 $63,297 - $74,143
-707 Reduced 0.82%
85,913 $8.1 Million
Q1 2023

May 01, 2023

BUY
$94.11 - $123.02 $2.07 Million - $2.71 Million
21,990 Added 34.02%
86,620 $8.77 Million
Q4 2022

Feb 07, 2023

SELL
$106.72 - $127.06 $443,421 - $527,934
-4,155 Reduced 6.04%
64,630 $7.72 Million
Q3 2022

Oct 25, 2022

SELL
$92.03 - $107.81 $27,240 - $31,911
-296 Reduced 0.43%
68,785 $7.31 Million
Q2 2022

Aug 08, 2022

BUY
$75.79 - $100.07 $138,316 - $182,627
1,825 Added 2.71%
69,081 $6.73 Million
Q1 2022

May 06, 2022

SELL
$72.45 - $94.81 $82,593 - $108,083
-1,140 Reduced 1.67%
67,256 $6.31 Million
Q4 2021

Feb 08, 2022

SELL
$79.65 - $106.22 $128,794 - $171,757
-1,617 Reduced 2.31%
68,396 $5.83 Million
Q3 2021

Oct 28, 2021

SELL
$86.18 - $99.03 $38,350 - $44,068
-445 Reduced 0.63%
70,013 $6.72 Million
Q2 2021

Jul 27, 2021

BUY
$89.43 - $102.27 $24,861 - $28,431
278 Added 0.4%
70,458 $6.86 Million
Q1 2021

May 03, 2021

BUY
$87.57 - $119.4 $6.15 Million - $8.38 Million
70,180 New
70,180 $6.83 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.